Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A W te Boekhorst

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Advances in Hematology|March 9, 2012
JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative NeoplasmsMar Bellido, Peter A W Te Boekhorst
Haematologica|September 25, 2025
Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosisRuben Van Dijck, John-John B Schnog, Peter A W Te Boekhorst
Frontiers in Oncology|August 27, 2019
New Approaches and Treatment Combinations for the Management of Chronic Myeloid LeukemiaPeter E Westerweel, Peter A W Te Boekhorst, Mark-David Levin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2021
Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case seriesF Nanne Croles, Peter A W Te Boekhorst, Frank W G Leebeek, et al.
Hematology (Amsterdam, Netherlands)|September 10, 2011
Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostimMarc Michel, Peter A W te Boekhorst, Ann Janssens, et al.
Blood Advances|February 11, 2021
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasmsEva N Hamulyák, Joost G Daams, Frank W G Leebeek, et al.
Biomedicines|July 29, 2023
Measuring Mitochondrial Oxygen Tension during Red Blood Cell Transfusion in Chronic Anemia Patients: A Pilot StudyRinse Ubbink, Lucia W J M Streng, Nicolaas J H Raat, et al.
Journal of Transplantation|March 28, 2014
The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam ExperienceMadelon van Agteren, Willem Weimar, Annelies E de Weerd, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2019
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the LiteratureStefanie Slot, Reinier A P Raymakers, Nicolaas Schaap, et al.
Haematologica|November 17, 2018
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysisAlessandro M Vannucchi, Peter A W Te Boekhorst, Claire N Harrison, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Advances in Hematology|March 9, 2012
JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative NeoplasmsMar Bellido, Peter A W Te Boekhorst
Haematologica|September 25, 2025
Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosisRuben Van Dijck, John-John B Schnog, Peter A W Te Boekhorst
Frontiers in Oncology|August 27, 2019
New Approaches and Treatment Combinations for the Management of Chronic Myeloid LeukemiaPeter E Westerweel, Peter A W Te Boekhorst, Mark-David Levin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2021
Therapeutic plasma exchange for anticoagulant-refractory antiphospholipid syndrome with severe ischemic and necrotic skin lesions: A case seriesF Nanne Croles, Peter A W Te Boekhorst, Frank W G Leebeek, et al.
Hematology (Amsterdam, Netherlands)|September 10, 2011
Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostimMarc Michel, Peter A W te Boekhorst, Ann Janssens, et al.
Blood Advances|February 11, 2021
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasmsEva N Hamulyák, Joost G Daams, Frank W G Leebeek, et al.
Biomedicines|July 29, 2023
Measuring Mitochondrial Oxygen Tension during Red Blood Cell Transfusion in Chronic Anemia Patients: A Pilot StudyRinse Ubbink, Lucia W J M Streng, Nicolaas J H Raat, et al.
Journal of Transplantation|March 28, 2014
The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam ExperienceMadelon van Agteren, Willem Weimar, Annelies E de Weerd, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2019
Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life: Results in Dutch Patients and Review of the LiteratureStefanie Slot, Reinier A P Raymakers, Nicolaas Schaap, et al.
Haematologica|November 17, 2018
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysisAlessandro M Vannucchi, Peter A W Te Boekhorst, Claire N Harrison, et al.
Pageof 3